Ruijie Ming

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Regulatory T cells in breast cancer drivers of immune suppression and targets for immunotherapy.

Regulatory T cells in breast cancer drivers of immune suppression and targets for immunotherapy.

Journal: Frontiers in immunology

Published: March 08, 2026

Corrigendum to "Structural and anti-colorectal cancer modulation of tumor necrosis factor-alpha (TNF-α) protein by gaillardin: Experimental and theoretical analyses" [Int. J. Biol. Macromol. Volume 340, Part 1, January 2026, 149705].

Corrigendum to "Structural and anti-colorectal cancer modulation of tumor necrosis factor-alpha (TNF-α) protein by gaillardin: Experimental and theoretical analyses" [Int. J. Biol. Macromol. Volume 340, Part 1, January 2026, 149705].

Journal: International journal of biological macromolecules

Published: January 25, 2026

Structural and anti-colorectal cancer modulation of tumor necrosis factor-alpha (TNF-α) protein by gaillardin: Experimental and theoretical analyses.

Structural and anti-colorectal cancer modulation of tumor necrosis factor-alpha (TNF-α) protein by gaillardin: Experimental and theoretical analyses.

Journal: International journal of biological macromolecules

Published: October 28, 2025

Macrophage-Induced Senescent Cancer-Associated Fibroblasts Promote SASP-Mediated Chemoresistance in Colorectal Cancer.

Macrophage-Induced Senescent Cancer-Associated Fibroblasts Promote SASP-Mediated Chemoresistance in Colorectal Cancer.

Journal: Cancer research

Published: October 25, 2025

GLANCE: continuous global-local exchange with consensus fusion for robust nodule segmentation.

GLANCE: continuous global-local exchange with consensus fusion for robust nodule segmentation.

Journal: NPJ digital medicine

Published: October 08, 2025

Epigenetic silencing of DLEC1 correlates with tumor immune microenvironment and predicts immunotherapy prognosis in multiple cancers.

Epigenetic silencing of DLEC1 correlates with tumor immune microenvironment and predicts immunotherapy prognosis in multiple cancers.

Journal: Human genetics

Published: October 08, 2025

Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition.

Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition.

Journal: Oncogene

Published: March 12, 2025

Integrative analysis of m6A-SNPs and single-cell RNA sequencing reveals key drivers of endocrine combined with CDK4/6 inhibitor therapy resistance in ER+ breast cancer.

Integrative analysis of m6A-SNPs and single-cell RNA sequencing reveals key drivers of endocrine combined with CDK4/6 inhibitor therapy resistance in ER+ breast cancer.

Journal: Frontiers in pharmacology

Published: March 09, 2025

A deep learning-based multimodal medical imaging model for breast cancer screening.

A deep learning-based multimodal medical imaging model for breast cancer screening.

Journal: Scientific reports

Published: November 11, 2024

Promoter Hyper-methylation of ZNF662 Restrains its Tumor Suppressing Function in Triple-Negative Breast Cancer Through Regulating NGF Signaling Axis.

Promoter Hyper-methylation of ZNF662 Restrains its Tumor Suppressing Function in Triple-Negative Breast Cancer Through Regulating NGF Signaling Axis.

Journal: International journal of biological sciences

Published: August 28, 2024

Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a mendelian randomization study.

Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a mendelian randomization study.

Journal: Scientific reports

Published: July 09, 2024

Causal effects and metabolites mediators between immune cell and risk of breast cancer: a Mendelian randomization study.

Causal effects and metabolites mediators between immune cell and risk of breast cancer: a Mendelian randomization study.

Journal: Frontiers in genetics

Published: February 26, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026